The first time I set up a stall
Release time:
2020-07-22
My first stall
6# May 12 was a special day for me. On this day, I stood on the People's Square for the first time; on this day, I communicated with many strangers for the first time; on this day, I set up a stall for the first time.
In the past, stalls would be driven away by urban management, and people did not think highly of stalls. Otherwise, "stalls " would not be a derogatory term. But now great changes have taken place. The state strongly advocates "stall economy " . Local governments have responded positively and invited our small and medium-sized enterprises to set up stalls. Therefore, the stall has also become a tall. Therefore, when I received the task, I did not resist it very much and even looked forward to it a little. But really to the scene, I became a little overwhelmed.
The People's Square in the morning can be said to be very lively. There are old people who come to do morning exercises, aunts who come to dance in the square, and elder sister who goes home after buying vegetables and passes by the square... That is to say, there are many guests who come to visit the stalls. The first time I stood in front of the booth, facing the sight of strangers coming and going, I was a little nervous, and I didn't dare to look at the guests or yell. Until our two managers came over, they put the products on the booth neatly and put the gifts away together. Then they picked up the leaflets and began to distribute them to passers-by while shouting.
"Grandpa came to see our products of Jianfeng, our health products of Jianfeng Health. " The manager handed out two leaflets to a grandpa who passed by while patiently introducing our products to him. After the manager's introduction, grandpa was a little moved, but said he didn't bring cash. Our manager also hurriedly added: "Grandpa can also come next time, we set up a 5 day stall here. " Grandpa looked at our stall number, then left a phone number and left.
I studied silently beside me, but I didn't take the first step. The manager obviously noticed me and let me confidently stand up and hand out leaflets to my grandparents and yell twice. I took the flyer and whispered: "Grandpa and Grandma have a look. " and handed it over. However, it seems that I shouted in a low voice, and my grandparents looked at it and walked away. But after I shouted for the first time, I felt less nervous, and then raised my volume to communicate with more people. In the end, I naturally shouted out, and several people were willing to stop and listen to my introduction, although few of them bought it. I think maybe it's because grandparents just go out for a walk and don't bring cash to buy things, and grandparents are not very good at paying with smartphones. In the next few days, several grandfathers came to buy our products with cash, which also confirmed my guess.
After this stall, I realized another way of sales, which can dig out potential customers and tap the market for the elderly. In the modern society with developed network, most of the customers of various online virtual stores are young people. Because of the complexity of smart phones, middle-aged and elderly people are not very good at using them. Middle-aged and elderly people still prefer physical stores. So, I'm a big supporter of the current stall economy, where all of us are part of the economic cycle. At the same time, our peak health also actively respond to and participate in the call of the country, and contribute to economic development. (Yang Rui)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31